ICU Medical Q3 Adj EPS $1.57 Beats $1.38 Estimate, Sales $553.31M Miss $565.75M Estimate
Portfolio Pulse from bharat@benzinga.com
ICU Medical reported Q3 earnings of $1.57 per share, beating the analyst consensus estimate of $1.38 by 13.77%. However, this is a 10.29% decrease from the same period last year. The company's quarterly sales were $553.31 million, missing the analyst consensus estimate of $565.75 million by 2.20%. This is a 7.45% decrease from the same period last year.
November 06, 2023 | 9:16 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ICU Medical's Q3 earnings beat estimates but decreased 10.29% YoY. Sales missed estimates and decreased 7.45% YoY.
ICU Medical's earnings beat estimates, which is positive. However, the YoY decrease in earnings and sales, as well as the missed sales estimate, could negatively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100